We previously described a decrease in MMP-9 and MMP-2 mRNA expression and enzymatic activity in breast (MCF-7), cervical (HeLa), lung (A549), and bladder (T24) cancer cells treated by aminoalkanol xanthone derivatives [23]. Here, MMP9 is linked to cancer.